Publication: Placebo Response in Binge Eating Disorder
Open/View Files
Date
2007
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley Subscription Services, Inc., A Wiley Company
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Jacobs-Pilipski, M. Joy, Denise E. Wilfley, Scott J. Crow, B. Timothy Walsh, Lisa R. R. Lilenfeld, Delia Smith West, Robert I. Berkowitz, James I. Hudson, and Christopher G. Fairburn. 2007. Placebo response in binge eating disorder. The International Journal of Eating Disorders 40(3): 204-211.
Research Data
Abstract
Objective: Placebo response in studies of binge eating disorder (BED) has raised concern about its diagnostic stability. The aims of this study were (1) to compare placebo responders (PRs) with nonresponders (NRs); (2) to investigate the course of BED following placebo response; and (3) to examine attributions regarding placebo response. Method: The baseline placebo run-in phase (BL) was part of a RCT investigating sibutramine hydrochloride for BED; it included 451 participants, ages 19–63, diagnosed with BED. Follow-up (FU) included 33 PRs. Results: In this study, 32.6% of participants responded to placebo (PRs = 147; NRs = 304). PRs exhibited significantly less symptom severity. At FU (n = 33), many PRs reported continued symptoms. Conclusion: PRs exhibited significantly less severe pathology than NRs. Placebo response in BED may transitory or incomplete. The results of this study suggest variable stability in the BED diagnosis.
Description
Other Available Sources
Keywords
binge eating disorder, placebo response, eating disorders, psychopathology
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service